Biotech Showcase is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Walt Kowtoniuk
Principal at Third Rock Ventures


Walt is a company creator with nearly a decade of experience working at the intersection of strategy and science. At Third Rock, Walt focuses on discovering, launching, and building companies aimed at treating rare genetic diseases and transforming the lives of patients. He first joined Third Rock in 2013 as a senior associate and returned in 2018 as a principal. Walt was involved in the launch of Fulcrum Therapeutics and Goldfinch Bio. Walt was integral in the creation and building of Fulcrum Therapeutics, joining the company full time to lead strategy, business development, and operations. As part of the leadership team, he was involved in advancing the pipeline to its first clinical candidate and growing the company to 40+ employees. Walt has also worked in strategy consulting with Clarion Healthcare developing new business strategies and providing commercial insight into early product development in the rare disease space. He has a Ph.D. in chemical biology from Harvard University and a B.S. in biochemistry, molecular biology, and philosophy from Gettysburg College. Walt is also a member of Corporate Advisory Council for National Tay-Sachs and Allied Diseases (NTSAD).

Agenda Sessions

  • The shifting model: How new era, patient-led collaborations are transforming drug discovery and development in rare disease, and beyond - Hilton Union Square


Speakers at this event